---
schema_version: "secwatch.filing_event.v1"
accession: "0001601485-23-000086"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2023-12-22T23:59:59+00:00"
generated_at: "2026-06-07T07:54:33.486390+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Elicio Therapeutics raises $7M via private placement at $5.81/share to board-affiliated entity

## Summary
- Private placement of 1,213,000 shares at $5.81 per share to GKCC, LLC, controlled by a board member.
- Gross proceeds of ~$7.0M; net proceeds for pipeline advancement, working capital, and general corporate purposes.
- Closing expected on December 22, 2023, subject to customary conditions.
- Company must file a resale registration statement with SEC by March 31, 2024.
- Securities are unregistered; sold under Section 4(a)(2) and Rule 506 of Regulation D.

## SEC filing metadata
- accession: 0001601485-23-000086
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2023-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000160148523000086/0001601485-23-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000160148523000086/angn-20231222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601485-23-000086
- JSON: https://secwatch.observer/filing/0001601485-23-000086.json
- Plain text: https://secwatch.observer/filing/0001601485-23-000086.txt

## Key facts
- Material Agreements
  Elicio Therapeutics, Inc. entered into Subscription Agreement with GKCC, LLC valued at approximately $7.0 million (effective 2023-12-22).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: GKCC, LLC
  - Value: approximately $7.0 million
  - Effective: 2023-12-22
  source text: On December 22, 2023, Elicio Therapeutics, Inc. (the “Company”) entered into a Subscription Agreement (the “Subscription Agreement”) with GKCC, LLC (the “Purchaser”), an entity controlled by a director of the Company, providing for the issuance and sale by the Company to the Purchaser of an aggregate of 1,213,000 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a purchase price per Share of $5.81 (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1601485/000160148523000086/0001601485-23-000086-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.